Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) and ICC Labs Inc. (ICC) (TSX-V: ICC) are pleased to announce that Aurora has received, from its consortium of lenders led by Bank of Montreal (collectively, the Lenders), consent and approval as required under its credit agreement with the Lenders to the previously announced plan of arrangement (the Arrangement) between ICC and Aurora. Subject to the terms and conditions of the arrangement agreement dated September 8, 2018 (the Arrangement Agreement), Aurora will acquire all of the issued and outstanding common shares (ICC Shares) of ICC.

Cannabis stocks are rebounding across the board today! Candian cannabis penny stocks are all trading in the green on the TSXV today, as well as major cannabis stocks on the NYSE. Today, we’ll take a look at Canopy Growth and Aurora Cannabis stock shares.

Cannabis Stocks: Canopy Growth Corporation (NYSE:CGC)

Canopy Growth is headquartered in Smiths Falls, Ontario, and with its subsidiaries engages in growing, possession, and sale of medical cannabis in Canada. 

Good news for the cannabis industry has been few and far between since cannabis went legal up in Canada earlier this month, but Marimed Inc. (OTC:MRMD) is one significant exception. The United States-based cannabis consulting company closed up an incredible 15.17 percent to $4.48 Tuesday following the company’s recent announcement that they finalized the acquisition of New Jersey cannabis firm BSC Group, a multidisciplinary consulting company with a cannabis industry operational consulting focus.

The acquisition was considered a huge win for both MariMed and BSC Group according to statements given by leadership.

Molson Coors Brewing Co. expects to "secure a meaningful share" of the cannabis-infused beverage market when edibles are legalized in Canada, the company's CEO said.

"We will be in a ready-to-go position and, you know, one of the first on the playing field as the market opens up," said Mark R. Hunter in a conference call with analysts after the company released its third-quarter earnings report Wednesday.

Recreational cannabis products such as dried flower and pre-rolled joints became available for legal purchase in Canada on Oct. 17, but edibles won't be legalized until next year.

The marijuana industry simply keeps making history in 2018. So far this year we have:

The pullback in cannabis stocks in the past two weeks has hit the share prices of Canada’s top pot stocks hard, and investors who have been on the sidelines through the entire rally and subsequent plunge are wondering which marijuana companies represent the best buys today. Let’s take a look at HEXO (TSX:HEXO) to see if it deserves to be in your portfolio right now.

Value play?

The entire cannabis sector continues to trade at valuations that are expensive, regardless of the metrics used to calculate what these companies might be worth.

Canopy Growth (TSX:WEED)(NYSE:CGC) is currently trading back at levels last seen in August, which, in isolation, is nothing to write about. But if we consider that the stock is down 43% since mid-October highs, the volatility behind this stock becomes clear.

What’s changing here?

Well, it all comes down to expectations, sentiment, and multiples. This is why I have not been focusing on the fundamentals of these marijuana stocks. When a stock is trading on sentiment, as these stocks have been doing, this is what matters and will matter in the short term, at least.

Like Godzilla rampaging through a city in a low-budget movie, the market meltdown among marijuana stocks has left plenty of carnage in its wake. Many marijuana stocks plunged 25% or more.

The good news is that in the midst of the mayhem, there are several stocks that look really attractive now. Three that stand out are Constellation Brands (NYSE:STZ), Liberty Health Sciences (NASDAQOTH:LHSIF), and Origin House(NASDAQOTH:ORHOF). Here's why these are three marijuana stocks you might want to buy after the market meltdown.

Those that scoffed at upstart companies centering their business on the cannabis industry, mocking them at every chance, couldn’t have been more wrong. Several of these once “penny stocks” have evolved into billion-dollar international industry giants, some of which now trade on the New York Stock Exchange, Nasdaq and Toronto Stock Exchange. The good news for investors still looking at the cannabis space is that plenty of upside remains with opportunities not only in North America, but worldwide as the nascent cannabis movement continues to evolve.

Navdeep Dhaliwal was surprised when he first stepped foot in Lesotho last January — the climate was temperate, the landscape was lush, and the first footprints of a legal medical marijuana system were already in place.

“A close friend in the industry put me in touch with guys in Lesotho. So I went to meet with them, and I was really very surprised and impressed by the operation they had going there,” said Dhaliwal, president of Canadian licensed producer Supreme Cannabis.